The deleterious effect of the PPARγ expression and variants were also studied, indicating no association between the Pro12Ala polymorphism and prostate cancer [151], suggesting therefore that PPARγ does not promote prostate cancer development [154]. Here, PPARG is linked to prostate carcinoma.